HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 242 filers reported holding HORIZON PHARMA PLC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $6,388,000 | +40.8% | 241,692 | +4.1% | 0.07% | +28.3% |
| Q4 2018 | $4,536,000 | +132.1% | 232,162 | +132.7% | 0.05% | +130.4% |
| Q3 2018 | $1,954,000 | +82.4% | 99,771 | +54.2% | 0.02% | +64.3% |
| Q2 2018 | $1,071,000 | +169.1% | 64,700 | +131.1% | 0.01% | +133.3% |
| Q1 2018 | $398,000 | -75.9% | 28,000 | -75.3% | 0.01% | -79.3% |
| Q4 2017 | $1,654,000 | +13.1% | 113,256 | -1.8% | 0.03% | +3.6% |
| Q3 2017 | $1,462,000 | +484.8% | 115,332 | +581.0% | 0.03% | +300.0% |
| Q1 2017 | $250,000 | -11.3% | 16,936 | -3.0% | 0.01% | -41.7% |
| Q4 2016 | $282,000 | -53.5% | 17,456 | -47.9% | 0.01% | -70.0% |
| Q3 2016 | $607,000 | +32.5% | 33,500 | +45.0% | 0.04% | -64.9% |
| Q3 2015 | $458,000 | -85.3% | 23,100 | -74.3% | 0.11% | -88.7% |
| Q2 2015 | $3,120,000 | – | 89,800 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |